precision medicine

Kalle Killar, deputy secretary general at the Ministry of Social Affairs in Estonia, says that nearly 20% of the country's citizens are gene donors, giving it a very valuable asset for implementing precision medicine.

Flare Capital Partners offers an overview of sequencing options, opportunities for integration into clinical workflow and the companies making that happen.

With more than 230,000 people across the US engaged in the program, the NIH and its partners detailed upcoming data analysis tools for researchers and the general public.

Bryce Olson, healthcare strategist at Intel, shares his remarkable precision medicine survival story and how his work is empowering other cancer patients.

Consumers aged 65 years or older were also the most likely demographic to believe that their treatments aren't being optimized on a personal level.

Neil Jordan, Worldwide Health Leader and Connector at Microsoft, says there is great potential for AI in healthcare but be aware of such issues as ethics and regulations.

The companies' partnership is yet another example of real-world data analysis coming to clinical trials.

According to Moshe Bar Siman-Tov, director general of Israel's Ministry of Health, the country is pushing towards preventative and personalized medicine.

University of Colorado Assistant Professor Mustafa Ozkaynak argues that getting insights about a patient's environment and lifestyle is just as critical as understanding genomic data.